组织陈列-产品详情

home > TISSUE ARRAYS > Multiple organ > MBC108

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

108

CASES:

108

Core Diameter(mm):

1

Thickness(µm):

5

Row number:

9

Column number:

12

Tissue Array Type:

FFPE

Species:

Human

MBC108

$284.00

Add To Collect

Description: Multiorgan abnormal tissue array, 108 cases/108 cores

Details: Multiorgan abnormal tissue microarray, containing 27 pathological types，each type taken from 4 human individuals, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

108 Cores 108 Cases Multiple organ

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Malignant(IB1)
Malignant(IB2)
Benign tumor(*)
Benign lesion(*)
Malignant(*)
*(*)
Malignant(IIIA1)
Malignant(I)
Malignant(IA)
Malignant(IB)
Malignant(IIA)
Malignant(IIB)
Malignant(II)
Malignant(IIIA)
Malignant(IIIB)
Malignant(IIIC)
Malignant(III)
Malignant(IVA)
_Ma

TISSUE ARRAYS
MBC108

	1	2	3	4	5	6	7	8	9	10	11	12
A	Bre	Bre	Bre	Bre	Nas	Pos	Nas	Nas	Bre	Bre	Bre	Bre
B	Gro	Gro	Arm	Col	Pan	Pan	Pan	Pan	Thy	Thy	Thy	Thy
C	Ova	Ova	Ova	Ova	Cer	Cer	Cer	Cer	Ute	Ute	Ute	Ute
D	Sto	Sto	Sto	Sto	Lun	Lun	Lun	Lun	Bla	Bla	Bla	Bla
E	Lun	Lun	Lun	Lun	Col	Col	Rec	Rec	Col	Rec	Rec	Col
F	Eso	Eso	Eso	Eso	Liv	Liv	Liv	Liv	Sto	Abd	Sma	Col
G	Pan	Pan	Pan	Pan	Kid	Kid	Kid	Kid	Lun	Lun	Lun	Lun
H	Ute	Ute	Ute	Ute	Pro	Pro	Pro	Pro	Sto	Sto	Sto	Sto
I	Bre	Bre	Bre	Bre	Pro	Pro	Pro	Pro	Gal	Gal	Gal	Gal	_Ma

MBC108

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type
A1	1	45	F	Breast	Invasive carcinoma	2	T2N0M0	IIA	Malignant
A2	2	63	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant
A3	3	33	F	Breast	Invasive carcinoma	3	T2N0M0	IIA	Malignant
A4	4	52	F	Breast	Invasive carcinoma	2	T2N0M0	IIA	Malignant
A5	5	57	F	Nasal cavity	Malignant melanoma	*	T3N0M0	III	Malignant
A6	6	30	M	Posterior pharyngeal wall	Malignant melanoma(sparse)	*	T3N0M0	III	Malignant
A7	7	76	F	Nasal cavity	Malignant melanoma	*	T3N0M0	III	Malignant
A8	8	54	M	Nasal cavity	Malignant melanoma	*	T4aN0M0	IVA	Malignant
A9	9	48	F	Breast	Hyperplasia	*	*	*	Benign lesion
A10	10	38	F	Breast	Hyperplasia	*	*	*	Benign lesion
A11	11	46	F	Breast	Hyperplasia	*	*	*	Benign lesion
A12	12	44	F	Breast	Hyperplasia	*	*	*	Benign lesion
B1	13	47	M	Groin	Diffuse large B-cell lymphoma	*	*	*	Malignant
B2	14	42	M	Groin	Diffuse large B-cell lymphoma	*	*	*	Malignant
B3	15	53	M	Armpit	Diffuse large B-cell lymphoma	*	*	*	Malignant
B4	16	43	F	Colon	Diffuse large B-cell lymphoma	*	*	*	Malignant
B5	17	29	F	Pancreas	Islet cell tumor	*	T3N0M0	II	Malignant
B6	18	35	F	Pancreas	Islet cell tumor	*	T1N0M0	I	Malignant
B7	19	58	M	Pancreas	Islet cell tumor	*	T1N0M0	I	Malignant
B8	20	39	M	Pancreas	Solid pseudopapillary tumor	*	*	*	*
B9	21	44	F	Thyroid gland	Papillary carcinoma	2	T2N0M0	I	Malignant
B10	22	28	F	Thyroid gland	Papillary carcinoma	1	T2N0M0	I	Malignant
B11	23	63	M	Thyroid gland	Papillary carcinoma	1	T2N1M0	II	Malignant
B12	24	36	F	Thyroid gland	Papillary carcinoma	2	T2N0M0	I	Malignant
C1	25	36	F	Ovary	High-grade serous adenocarcinom with necrosis(sparse)	2	T2bN0M0	IIB	Malignant
C2	26	57	F	Ovary	High-grade serous adenocarcinom	3	T2bN1M0	IIIA1	Malignant
C3	27	56	F	Ovary	High-grade serous adenocarcinom (sparse)	2--3	T3bN1M0	IIIB	Malignant
C4	28	61	F	Ovary	Low grade serous adenocarcinoma	2	T3bN0M0	IIIB	Malignant
C5	29	38	F	Cervix	Invasive squamous cell carcinoma	2--3	T1b2N1M0	IIIB	Malignant
C6	30	46	F	Cervix	Squamous cell carcinoma	3	T1b1N0M0	IB1	Malignant
C7	31	50	F	Cervix	Invasive squamous cell carcinoma	2	T1b2N0M0	IB2	Malignant
C8	32	31	F	Cervix	Invasive squamous cell carcinoma	2	T1b1N1M0	IIIB	Malignant
C9	33	43	F	Uterus	Leiomyoma	*	*	*	Benign tumor
C10	34	37	F	Uterus	Leiomyoma	*	*	*	Benign tumor
C11	35	49	F	Uterus	Leiomyoma	*	*	*	Benign tumor
C12	36	44	F	Uterus	Leiomyoma	*	*	*	Benign tumor
D1	37	53	M	Stomach	Adenocarcinom	3	T4aN2M0	IIIA	Malignant
D2	38	35	F	Stomach	Adenocarcinom	3	T3N0M0	IIA	Malignant
D3	39	64	F	Stomach	Adenocarcinom	2	T4aN1M0	IIIA	Malignant
D4	40	60	M	Stomach	Adenocarcinom (sparse)	3	T4aN1M0	IIIA	Malignant
D5	41	61	M	Lung	Squamous cell carcinoma	2	T2aN0M0	IB	Malignant
D6	42	54	M	Lung	Squamous cell carcinoma with necrosis（sparse）	1--2	T2bN2M0	IIIA	Malignant
D7	43	70	M	Lung	Squamous cell carcinoma	3	T3N2M0	IIIB	Malignant
D8	44	58	M	Lung	Squamous cell carcinoma	3	T2aN2M0	IIIA	Malignant
D9	45	71	F	Bladder	Invasive papillary urothelial carcinoma	2	T3N0M0	III	Malignant
D10	46	65	M	Bladder	Invasive papillary urothelial carcinoma（sparse）。	2	T2aN0M0	II	Malignant
D11	47	54	M	Bladder	Papillary urothelial carcinoma (sparse)	2	T3N0M0	III	Malignant
D12	48	70	M	Bladder	Invasive papillary urothelial carcinoma	2--3	T2bN2M0	IIIB	Malignant
E1	49	42	M	Lung	Invasive adenocarcinoma	3	T2aN2M0	IIIA	Malignant
E2	50	64	F	Lung	Invasive adenocarcinoma	1	T2bN2M0	IIIA	Malignant
E3	51	39	F	Lung	Invasive adenocarcinoma	3	T3N2M0	IIIB	Malignant
E4	52	72	M	Lung	Invasive adenocarcinoma	3	T3N0M0	IIB	Malignant
E5	53	60	M	Colon	Adenocarcinom	2	T3N0M0	IIA	Malignant
E6	54	59	M	Colon	Adenocarcinom	3	T3N2bM0	IIIC	Malignant
E7	55	69	F	Rectum	Adenocarcinom	2	T3N0M0	IIA	Malignant
E8	56	62	M	Rectum	Adenocarcinom	2--3	T3N0M0	IIA	Malignant
E9	57	56	M	Colon	Adenoma	*	*	*	Benign tumor
E10	58	66	M	Rectum	Adenoma	*	*	*	Benign tumor
E11	59	59	M	Rectum	Adenoma	*	*	*	Benign tumor
E12	60	57	M	Colon	Adenoma	*	*	*	Benign tumor
F1	61	57	M	Esophagus	Squamous cell carcinoma	2	T2N1M0	II	Malignant
F2	62	61	M	Esophagus	Squamous cell carcinoma	2--3	T2N3M0	IVA	Malignant
F3	63	66	M	Esophagus	Adenosquamous carcinoma	2--3	T3N0M0	II	Malignant
F4	64	62	M	Esophagus	Squamous cell carcinoma	2	T2N0M0	II	Malignant
F5	65	53	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant
F6	66	61	M	Liver	Hepatocellular carcinoma	2	T4N0M0	IIIB	Malignant
F7	67	58	M	Liver	Hepatocellular carcinoma	2	T1bN0M0	IB	Malignant
F8	68	43	M	Liver	Hepatocellular carcinoma	2	T4N0M0	IIIB	Malignant
F9	69	71	M	Stomach	Low grade malignant gastrointestinal stromal tumor	*	T3N0M0	IB	Malignant
F10	70	51	M	Abdominal cavity	Malignant gastrointestinal stromal tumor	*	T4N0M0	IIIB	Malignant
F11	71	48	M	Small intestine	Gastrointestinal stromal tumor	*	T2N0M0	IA	Malignant
F12	72	81	F	Colon	Malignant gastrointestinal stromal tumor	*	T3N0M0	IIIB	Malignant
G1	73	68	F	Pancreas	Adenocarcinom	2--3	T3N0M0	IIA	Malignant
G2	74	51	F	Pancreas	Adenocarcinom	1--2	T2N0M0	IB	Malignant
G3	75	54	M	Pancreas	Adenocarcinom	2	T3N1M0	IIB	Malignant
G4	76	40	M	Pancreas	Adenocarcinom	2	T2N1M0	IIB	Malignant
G5	77	77	M	Kidney	Clear cell renal cell carcinoma	1-2	T1bN0M0	I	Malignant
G6	78	53	F	Kidney	Clear cell renal cell carcinoma	1-2	T3N0M0	III	Malignant
G7	79	56	M	Kidney	Clear cell renal cell carcinoma	2	T3N0M0	III	Malignant
G8	80	66	M	Kidney	Clear cell renal cell carcinoma	1-2	T1bN0M0	I	Malignant
G9	81	66	M	Lung	Interstitial tissue (sparse)	*	*	*	Benign lesion
G10	82	67	M	Lung	Chronic inflammation	*	*	*	Benign lesion
G11	83	63	M	Lung	Chronic inflammation	*	*	*	Benign lesion
G12	84	67	F	Lung	Chronic inflammation	*	*	*	Benign lesion
H1	85	60	F	Uterus	Endometrioid adenocarcinoma	2--3	T1bN0M0	IB	Malignant
H2	86	42	F	Uterus	Endometrioid adenocarcinoma	2	T1aN0M0	IA	Malignant
H3	87	48	F	Uterus	Endometrioid adenocarcinoma	2--3	T1aN0M0	IA	Malignant
H4	88	50	F	Uterus	Endometrioid adenocarcinoma	1--2	T1aN0M0	IA	Malignant
H5	89	74	M	Prostate	Adenocarcinom 3( 4+3=7)	3( 4+3=7)	T2aN0M0	I	Malignant
H6	90	71	M	Prostate	Adenocarcinom 1( 3+3=6)	1( 3+3=6)	T2aN0M0	I	Malignant
H7	91	72	M	Prostate	Adenocarcinom 4( 4+4=8)	4( 4+4=8)	T2cN0M0	II	Malignant
H8	92	80	M	Prostate	Adenocarcinom 4( 4+4=8)	4( 4+4=8)	T3aN0M0	III	Malignant
H9	93	71	M	Stomach	Chronic inflammation	*	*	*	Benign lesion
H10	94	53	M	Stomach	Chronic inflammation	*	*	*	Benign lesion
H11	95	66	M	Stomach	Chronic inflammation	*	*	*	Benign lesion
H12	96	71	M	Stomach	Chronic inflammation	*	*	*	Benign lesion
I1	97	53	F	Breast	Fibroadenoma	*	*	*	Benign tumor
I2	98	26	F	Breast	Fibroadenoma	*	*	*	Benign tumor
I3	99	46	F	Breast	Fibroadenoma	*	*	*	Benign tumor
I4	100	48	F	Breast	Fibroadenoma	*	*	*	Benign tumor
I5	101	68	M	Prostate	Hyperplasia	*	*	*	Benign lesion
I6	102	77	M	Prostate	Hyperplasia	*	*	*	Benign lesion
I7	103	71	M	Prostate	Hyperplasia	*	*	*	Benign lesion
I8	104	66	M	Prostate	Hyperplasia	*	*	*	Benign lesion
I9	105	57	F	Gallbladder	Chronic inflammation	*	*	*	Benign lesion
I11	107	46	M	Gallbladder	Chronic inflammation	*	*	*	Benign lesion
I10	106	70	M	Gallbladder	Chronic inflammation	*	*	*	Benign lesion
I12	108	53	F	Gallbladder	Chronic inflammation	*	*	*	Benign lesion
_Marker_

Find overlapping cases with this tissue array:

MBC108

File Format: .xlsx

Release Date: 2025-01-17 16:02:44
Download

	1	2	3	4	5	6	7	8	9	10	11	12
A	Bre	Bre	Bre	Bre	Nas	Pos	Nas	Nas	Bre	Bre	Bre	Bre
B	Gro	Gro	Arm	Col	Pan	Pan	Pan	Pan	Thy	Thy	Thy	Thy
C	Ova	Ova	Ova	Ova	Cer	Cer	Cer	Cer	Ute	Ute	Ute	Ute
D	Sto	Sto	Sto	Sto	Lun	Lun	Lun	Lun	Bla	Bla	Bla	Bla
E	Lun	Lun	Lun	Lun	Col	Col	Rec	Rec	Col	Rec	Rec	Col
F	Eso	Eso	Eso	Eso	Liv	Liv	Liv	Liv	Sto	Abd	Sma	Col
G	Pan	Pan	Pan	Pan	Kid	Kid	Kid	Kid	Lun	Lun	Lun	Lun
H	Ute	Ute	Ute	Ute	Pro	Pro	Pro	Pro	Sto	Sto	Sto	Sto
I	Bre	Bre	Bre	Bre	Pro	Pro	Pro	Pro	Gal	Gal	Gal	Gal	_Ma

	1	2	3	4	5	6	7	8	9	10	11	12
A	Bre	Bre	Bre	Bre	Nas	Pos	Nas	Nas	Bre	Bre	Bre	Bre
B	Gro	Gro	Arm	Col	Pan	Pan	Pan	Pan	Thy	Thy	Thy	Thy
C	Ova	Ova	Ova	Ova	Cer	Cer	Cer	Cer	Ute	Ute	Ute	Ute
D	Sto	Sto	Sto	Sto	Lun	Lun	Lun	Lun	Bla	Bla	Bla	Bla
E	Lun	Lun	Lun	Lun	Col	Col	Rec	Rec	Col	Rec	Rec	Col
F	Eso	Eso	Eso	Eso	Liv	Liv	Liv	Liv	Sto	Abd	Sma	Col
G	Pan	Pan	Pan	Pan	Kid	Kid	Kid	Kid	Lun	Lun	Lun	Lun
H	Ute	Ute	Ute	Ute	Pro	Pro	Pro	Pro	Sto	Sto	Sto	Sto
I	Bre	Bre	Bre	Bre	Pro	Pro	Pro	Pro	Gal	Gal	Gal	Gal	_Ma

	1	2	3	4	5	6	7	8	9	10	11	12
A	Bre	Bre	Bre	Bre	Nas	Pos	Nas	Nas	Bre	Bre	Bre	Bre
B	Gro	Gro	Arm	Col	Pan	Pan	Pan	Pan	Thy	Thy	Thy	Thy
C	Ova	Ova	Ova	Ova	Cer	Cer	Cer	Cer	Ute	Ute	Ute	Ute
D	Sto	Sto	Sto	Sto	Lun	Lun	Lun	Lun	Bla	Bla	Bla	Bla
E	Lun	Lun	Lun	Lun	Col	Col	Rec	Rec	Col	Rec	Rec	Col
F	Eso	Eso	Eso	Eso	Liv	Liv	Liv	Liv	Sto	Abd	Sma	Col
G	Pan	Pan	Pan	Pan	Kid	Kid	Kid	Kid	Lun	Lun	Lun	Lun
H	Ute	Ute	Ute	Ute	Pro	Pro	Pro	Pro	Sto	Sto	Sto	Sto
I	Bre	Bre	Bre	Bre	Pro	Pro	Pro	Pro	Gal	Gal	Gal	Gal	_Ma